Asunción S.
- Country
- Spain
- Department
- Nephrology
Research Overview
- Efficacy and Safety of Intravenous Ravulizumab in Reducing Delayed Graft Function in High-Risk Adult Kidney Transplant Recipients: A Phase 3 Randomized Study
- Evaluation of Reduced Immunosuppression Regimen with Tacrolimus, Prednisolone, and Mycophenolate Sodium in Older Adult Kidney Transplant Recipients with End-Stage Renal Disease
Data & Insights
Has run more than one trial at 9 of 39 partner sites.
Specializations
Kidney disease and renal replacement care
Asunción Sancho is involved in clinical research centered on chronic kidney disease, end-stage kidney disease, IgA nephropathy, focal segmental glomerulosclerosis, and lupus nephritis, with additional interest in kidney-related complications after transplantation and dialysis.
- Chronic kidney disease and non-diabetic chronic kidney disease
- IgA nephropathy and glomerulonephritis
- Kidney transplantation and delayed graft function
- Dialysis and peritoneal dialysis
Her research landscape also includes kidney-protective strategies, proteinuria reduction, and management of hyperkalemia and renal inflammation.
Autoimmune disease and systemic inflammatory disorders
Her clinical trial activity extends to systemic lupus erythematosus, systemic sclerosis, bullous pemphigoid, Sjögren’s syndrome, and cutaneous lupus erythematosus, reflecting a strong focus on immune-mediated disease.
- Systemic lupus erythematosus and lupus nephritis
- Systemic sclerosis and diffuse cutaneous systemic sclerosis
- Bullous pemphigoid and autoimmune skin disease
- Sjögren’s syndrome and immune system diseases
She is also involved in studies addressing interstitial lung disease linked to autoimmune conditions and broader rheumatic disease manifestations.
Hematologic malignancies and plasma cell disorders
Another major area of interest is oncology, especially multiple myeloma, smoldering multiple myeloma, follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma, and myelofibrosis.
- Multiple myeloma and relapsed or refractory myeloma
- Follicular lymphoma and marginal zone lymphoma
- Diffuse large B-cell lymphoma
- Myelofibrosis and essential thrombocythemia
Her trial portfolio also covers plasma cell dyscrasias and treatment strategies for high-risk precursor hematologic conditions.
Neurodegenerative and cognitive disorders
She participates in studies on Alzheimer’s disease, mild cognitive impairment, mild dementia, early Parkinson’s disease, and multiple sclerosis, indicating sustained involvement in neurological therapeutics.
- Alzheimer’s disease and early symptomatic Alzheimer’s disease
- Mild cognitive impairment and mild dementia
- Multiple sclerosis
- Parkinson’s disease
Her research interest includes cognitive decline, neuroinflammation, and disorders affecting brain function and nervous system disease.
Respiratory, cardiovascular, and metabolic conditions
Her clinical research also spans severe asthma, chronic obstructive pulmonary disease, interstitial lung disease, acute pulmonary embolism, and atherosclerotic cardiovascular disease, with additional work in obesity and type 2 diabetes-associated risk.
- Severe asthma and eosinophilic asthma
- Chronic obstructive pulmonary disease
- Acute pulmonary embolism
- Obesity and cardiorenal disease
She is additionally engaged in studies on community-acquired pneumonia, pulmonary arterial hypertension, and cardiometabolic risk in patients with kidney disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.